Dr
Claire
Irvine

Partner & Patent Attorney

London Office Oxford Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 794 706 5907
Email. [email protected]

Experience

From her first days in the patent profession, Claire has been involved with many of the major innovations in the life sciences’ field. These have spanned immunology-related therapeutics, RNA therapeutics, synthetic biology and genetic diagnostics, including applications of bioinformatics. This continues as a partner of both the specialist HGF CRISPR and microbiome IP teams.

Claire has extensive experience of opposition and appeal proceedings at the European Patent Office, including both defending and opposing high profile patents which have attracted much interest beyond patent professionals. This has included patents from the early days of recombinant antibodies through to controversial patents arising from gene discovery and more recently, much publicised patents for gene-editing technologies.

Claire also has much experience of handling patent portfolios demanding inter-disciplinary input including in the fields of bioinformatics and medical and diagnostic devices. This has included much in the application of high-throughput nucleic acid sequencing technologies such as non-invasive foetal testing and cancer diagnostics.

As one of the most experienced patent partners’ of the life science team, Claire has the reputation of being able to apply creative thinking to turn around the most difficult IP problems. She has been responsible for building the IP portfolios of a number of companies and continues to enjoy the challenge of advising on freedom-to-operate and IP strategy.

Qualifications

Patent Attorney

Chartered (UK)
European


MA

MA(Oxon) Biochemistry with supplemental chemical pharmacology

PHD

PhD St George's Hospital Medical School

Recognition

IAM Patent 1000 listed in 2021

Accompanying quotes: a " fearless warrior"; "Claire pays meticulous attention to detail and has superb technical and scientific knowledge; clients can concentrate on their own growth knowing their IP is in safe hands."

View recognition online

Publications

Getting your first filing right

View publication online

WIPR Publication 10 April 2019: Life Sciences: it pays to be wary over CRISPR

View publication online

LSIPR article June 2019: Russian Scientist pledges to make more CRISPR- edited babies

View publication online

LSIPR article March 2020: Broad Institute down (but not out) in the European Fight over CRISPR IP

View publication online

Regular provider of WIPR webinars on the CRISPR IP saga

Conferences: 2022

May 10th 2022

The HGF IP in Healthcare Conference 2022

Speaker

Event details

March 23rd 2022

HGF webinar: Getting your first filing right

Speaker

Event details

Conferences: 2020

March 3rd 2020

IP in Healthcare Conference 2020

Speaker

Event details

Conferences: 2019

November 21st 2019

Life Sciences Patent Network Europe 2019

Speaker

Event details

June 27th 2019

Update on the CRISPR IP Saga and lessons to be learnt - Basel

Speaker

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

April 25th 2019

Life Science Patent Network North America - Boston

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Related News

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.